7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 
      
    		                                       
      revenue
    		479,533,000 444,328,000 483,649,000 646,542,000 621,401,000 647,145,000 639,653,000 556,055,000 511,015,000 469,136,000 427,690,000 382,432,000 352,585,000 319,939,000 297,057,000                         
      yoy
    		-22.83% -31.34% -24.39% 16.27% 21.60% 37.94% 49.56% 45.40% 44.93% 46.63% 43.98%                             
      qoq
    		7.92% -8.13% -25.19% 4.05% -3.98% 1.17% 15.03% 8.81% 8.93% 9.69% 11.83% 8.47% 10.20% 7.70%                          
      expenses
    		                                       
      cost of revenue
    		379,759,000 343,943,000 381,178,000 570,831,000 540,708,000 540,302,000 535,547,000 454,428,000 386,585,000 351,938,000 310,475,000 299,368,000 266,617,000 249,705,000 219,739,000 164,480,000 163,126,000 172,113,000 157,832,000 176,743,000 183,165,000 165,812,000 175,653,000                 
      gross profit
    		99,774,000 100,385,000 102,471,000 75,711,000 80,693,000 106,843,000 104,106,000 101,627,000 124,430,000 117,198,000 117,215,000 83,064,000 85,968,000 70,234,000 77,318,000                         
      yoy
    		23.65% -6.04% -1.57% -25.50% -35.15% -8.84% -11.18% 22.35% 44.74% 66.87% 51.60%                             
      qoq
    		-0.61% -2.04% 35.34% -6.17% -24.48% 2.63% 2.44% -18.33% 6.17% -0.01% 41.11% -3.38% 22.40% -9.16%                          
      gross margin %
    		20.81% 22.59% 21.19% 11.71% 12.99% 16.51% 16.28% 18.28% 24.35% 24.98% 27.41% 21.72% 24.38% 21.95% 26.03%                         
      selling, general and administrative expenses
    		77,592,000 75,209,000 78,409,000 47,701,000 67,060,000 69,185,000 79,104,000 81,428,000 96,567,000 90,389,000 89,726,000 82,861,000 68,521,000 58,955,000 58,932,000 66,917,000 51,292,000 42,699,000 58,591,000 61,633,000 55,758,000 50,511,000 54,698,000  58,808,000 66,932,000 74,838,000 175,852,000 59,566,000 57,403,000 55,526,000 159,836,000 45,834,000 51,090,000 53,550,000 122,294,000 38,398,000 32,756,000  
      depreciation and amortization expenses
    		23,615,000 23,141,000 24,058,000 29,296,000 29,701,000 29,870,000 29,503,000 29,602,000 32,404,000 32,134,000 29,275,000 19,781,000 17,196,000 15,112,000 15,106,000 15,075,000 14,859,000 14,916,000 15,187,000 14,865,000 14,694,000 15,778,000 16,138,000  15,408,000 15,292,000 14,266,000 34,163,000 10,352,000 10,034,000 9,496,000 24,651,000 7,717,000 6,904,000 6,615,000 13,478,000 3,746,000 3,612,000  
      gain on lease termination
    		-1,230,000                                       
      change in fair value of contingent consideration
    		-1,089,000 3,206,000 -280,000 -4,200,000 200,000  8,908,000 5,937,000 11,300,000 -7,822,000 8,569,000 -17,700,000 -12,700,000 800,000 6,078,000            100,000             
      total operating expenses
    		478,647,000 445,499,000 485,271,000 665,138,000 637,669,000 639,357,000 653,062,000 577,405,000 528,953,000 490,704,000 438,045,000 384,310,000 339,634,000 324,572,000 299,855,000 260,572,000 229,052,000 229,728,000 231,016,000 271,870,000 282,301,000 466,101,000 272,785,000  240,281,000 217,192,000 244,402,000 513,566,000 160,977,000 153,264,000 153,846,000 385,858,000 121,932,000 126,188,000 127,693,000 415,558,000 76,049,000 69,147,000  
      operating income
    		886,000 -1,171,000 -1,622,000 -18,596,000 -16,268,000 7,788,000 -13,409,000 -21,350,000 -17,938,000 -21,568,000 -10,355,000 -1,878,000 12,951,000 -4,633,000 -2,798,000 -12,214,000 -6,581,000 -7,671,000 -15,945,000 53,000 -17,708,000 -227,469,000 -25,500,000  -20,138,000 -25,233,000 -46,646,000 -36,450,000 -11,030,000 -8,966,000 -14,132,000 -58,820,000 -14,020,000 -19,117,000 -21,455,000 -221,580,000 -15,839,000 -12,629,000  
      yoy
    		-105.45% -115.04% -87.90% -12.90% -9.31% -136.11% 29.49% 1036.85% -238.51% 365.53% 270.09% -84.62% -296.79% -39.60% -82.45% -23145.28% -62.84% -96.63% -37.47%  -12.07% 801.47% -45.33%  82.57% 181.43% 230.07% -38.03% -21.33% -53.10% -34.13% -73.45% -11.48% 51.37%      
      qoq
    		-175.66% -27.81% -91.28% 14.31% -308.89% -158.08% -37.19% 19.02% -16.83% 108.29% 451.38% -114.50% -379.54% 65.58% -77.09% 85.59% -14.21% -51.89% -30184.91% -100.30% -92.22% 792.04%   -20.19% -45.91% 27.97% 230.46% 23.02% -36.56% -75.97% 319.54% -26.66% -10.90% -90.32% 1298.95% 25.42%   
      operating margin %
    		0.18% -0.26% -0.34% -2.88% -2.62% 1.20% -2.10% -3.84% -3.51% -4.60% -2.42% -0.49% 3.67% -1.45% -0.94%                         
      interest income
    		964,000 1,084,000 1,274,000 830,000 794,000 1,370,000 2,550,000 2,521,000 1,071,000 604,000 1,060,000 604,000 425,000 223,000 117,000 96,000 120,000 68,000 123,000 115,000 1,288,000 842,000 919,000  1,124,000 842,000 1,060,000 2,472,000 968,000 878,000 1,072,000 1,245,000 411,000 218,000 185,000 468,000 255,000 272,000  
      interest expense
    		-16,475,000 -11,601,000 -10,385,000 -6,720,000 -6,010,000 -5,995,000 -5,997,000 -12,238,000 -14,614,000 -14,458,000 -12,895,000 -6,429,000 -4,754,000 -2,148,000 -2,241,000 -6,447,000 -6,367,000 -6,274,000 -6,337,000 -8,340,000 -7,419,000 -6,293,000 -6,285,000  -3,630,000 -3,620,000 -3,562,000 -4,631,000 -853,000 -855,000 -853,000 -2,756,000 -880,000 -947,000 -954,000     
      gain from equity method investees
    		156,000 197,000 -19,000 182,000 -2,229,000 -1,700,000 306,000 28,000 684,000 155,000 423,000 629,000 1,392,000 1,952,000 596,000 454,000 63,000 4,879,000 7,783,000 -975,000 -13,717,000 25,143,000                  
      gain on extinguishment of short-term debt
    		431,000                                       
      loss on option exercise
    		 -196,000 -52,348,000                                     
      extinguishment of series a preferred stock and other refinancing fees
    		-6,000,000                                       
      change in tax receivables agreement liability
    		      -173,000 4,202,000                                
      other income
    		80,000 -35,000 -48,000 381,000 -43,000 -105,000 8,000 -220,000 -77,000 -26,000 -220,000 -73,000 -345,000 297,000 178,000 -73,000 -41,000 -18,000 -14,000 -289,000 -111,000 352,000 -71,000  -84,000 -587,000 427,000 233,000 -124,000 78,000 -18,000 156,000 15,000 3,000 2,000 3,000 1,000 1,000  
      income before income taxes
    		-19,958,000 -20,722,000 -63,148,000 -23,923,000 -23,756,000 1,358,000 -16,715,000 -48,067,000 -30,874,000 -35,293,000 -88,171,000                             
      benefit from income taxes
    		906,000 -825,000 1,470,000 -1,121,000 -619,000 -238,000 565,000 -14,656,000 -5,550,000 -970,000 -68,189,000 1,122,000 -45,516,000 -184,000 1,202,000    611,000                     
      income before preferred dividends and accretion of series a preferred stock including excise tax
    		-20,864,000                                       
      dividends and accretion of series a preferred stock including excise tax
    		-6,066,000                                       
      net income attributable to common shareholders of evolent health, inc.
    		-26,930,000 -51,090,000 -72,250,000 -30,615,000 -31,231,000 -6,383,000 -25,225,000 -41,395,000 -33,196,000 -41,411,000 -26,258,000 -11,349,000 2,123,000 -4,588,000 -5,350,000 -5,647,000 -13,040,000 -9,107,000 -9,807,000 -14,625,000 -37,348,000 -203,521,000 -78,752,000                 
      loss per common share
    		                                       
      basic and diluted
    		-240 -440 -630 -260 -270 -60 -220    -240         -70 -440 -2,380 -930                 
      weighted-average common shares outstanding
    		                                       
      basic and diluted
    		114,066,000 115,882,000 115,315,000 114,682,000 114,862,000 114,688,000 114,141,000 111,251  111,278,000 107,783,000 93,699  90,071 89,509 86,067 85,800 85,448 84,670 84,928,000 85,172,000 85,349,000 84,793,000 82,364,000 83,819,000 82,289,000 79,335,000 77,338,000            
      comprehensive loss
    		                                       
      other comprehensive loss, net of taxes, related to:
    		                                       
      foreign currency translation adjustment
    		-669,000 22,000 24,000 -386,000 -12,000 -47,000 -51,000 8 -151 8,000 56,000 -134 -262 -288 -132 1 4 -58 -31 42,000 71,000 -4,000 -153,000  -68,000 11,000 24,000 -66,000 -116,000 -148,000          
      total comprehensive loss attributable to common shareholders of evolent health, inc.
    		-27,599,000 -51,068,000 -72,226,000 -31,001,000 -31,243,000 -6,430,000 -25,276,000   -41,403,000 -26,202,000   -4,876 -5,482 -5,646 -13,036 -9,165 -9,838 -14,583,000 -37,277,000 -203,525,000 -78,905,000                 
      loss on lease termination
    		  1,906,000                                     
      extinguishment of series a preferred stock
    		 -9,000,000                                      
      income before preferred dividends and accretion of series a preferred stock
    		 -19,897,000 -64,618,000 -22,802,000 -23,137,000 1,596,000 -17,280,000 -33,411,000 -25,324,000 -34,323,000 -19,982,000                             
      dividends and accretion of series a preferred stock
    		 -31,193,000 -7,632,000 -7,813,000 -8,094,000 -7,979,000 -7,945,000 -7,984,000 -7,872,000 -7,088,000 -6,276,000                             
      loss on disposal of non-strategic assets
    		                                       
      right-of-use assets impairment
    		         24,065,000                              
      loss on disposal of assets
    		       524,250 2,097,000              6,447,000                 
      loss on repayment on long-term debt
    		                                       
      income from continuing operations
    		       -33,411,000 -25,324,000 -34,323,000  -11,349,000 2,123,000 -4,125,000 -5,350,000 3,053,000 -13,040,000 -9,107,000 -11,190,000                     
      income from discontinued operations, net of tax
    		             -463,000  -8,700,000                        
      income per common share
    		                                       
      basic:
    		                                       
      continuing operations
    		       -370 -300 -370  -120 20 -50 -60 40 -150 -110 -130                     
      discontinued operations
    		           -2.5    -110   10                     
      basic income per share attributable to common shareholders of evolent health, inc.
    		       -0.228 -0.3   -0.023 0.02                           
      diluted:
    		                                       
      diluted income per share attributable to common shareholders of evolent health, inc.
    		       -0.228 -0.3   -0.023 0.02                           
      weighted-average common shares outstanding
    		                                       
      basic
    		        112,282    95,286                77,999,000 77,209,000 75,375,000 64,351,000 70,328,000 59,478,000 52,599,000 45,031,000 43,110,000 42,594,000  
      diluted
    		        112,282    99,308                77,999,000 77,209,000 75,375,000 64,351,000 70,328,000 59,478,000 52,599,000 45,031,000 43,110,000 42,594,000  
      comprehensive income
    		                                       
      other comprehensive income, net of taxes, related to:
    		                                       
      total comprehensive income attributable to common shareholders of evolent health, inc.
    		       -25,238 -33,347   -2,124.25 1,861                           
      change in tax receivable agreement liability
    		          -66,184,000 -3,080,000 -42,870,000                           
      loss per common share
    		                                       
      basic and diluted:
    		                                       
      discontinued operations
    		           -2.5    -110   10                     
      basic and diluted
    		         -370                              
      net income
    		          -26,258,000 -11,349 2,123 -4,588 -5,350 -5,647,000 -13,040,000 -9,107,000 -9,807,000 -13,803,000 -38,170,000 -203,521,000 -78,752,000  -25,738,000 -31,900,000 -48,649,000 -41,636,000 -12,555,000 -10,031,000 -14,065,000 -56,638,000 -13,129,000 -19,698,000 -23,149,000 -211,003,000 -15,775,000 -11,999,000  
      yoy
    		          490703.74% -99.80% -100.02% -99.95% -99.95% -59.09% -65.84% -95.53% -87.55%  48.30% 538.00% 61.88%  105.00% 218.01% 245.89% -26.49% -4.37% -49.08% -39.24% -73.16% -16.77% 64.16%      
      qoq
    		          231268.40% -634.57% -146.27% -14.24% -99.91% -56.69% 43.19% -7.14% -28.95% -63.84% -81.25% 158.43%   -19.32% -34.43% 16.84% 231.63% 25.16% -28.68% -75.17% 331.40% -33.35% -14.91% -89.03% 1237.58% 31.47%   
      net income margin %
    		0% 0% 0% 0% 0% 0% 0% 0% 0% 0% -6.14% -0.00% 0.00% -0.00% -0.00%                         
      gain on transfer of membership
    		               22,969,000   22,969,000                     
      loss on extinguishment/repayment of debt
    		            -10,192,000                           
      income from continuing operations before income taxes
    		           -10,227,000 -43,393,000 -4,309,000 -4,148,000 2,600,000 -12,806,000 -9,016,000 -10,579,000                     
      loss on repayment of debt
    		               -2,185,000   -19,158,000                     
      basic and diluted loss per share attributable to common shareholders of evolent health, inc.
    		             -0.05 -0.06 -0.07 -0.15 -0.11 -0.12                     
      transformation services
    		               6,220,000 2,075,000 2,564,000 345,000 1,190,000 4,807,000 755,000 5,238,000  5,184,000 1,944,000 3,353,000 23,686,000 9,230,000 8,215,000 6,505,000         
      platform and operations services
    		               242,138,000 220,396,000 219,493,000 214,726,000 240,492,000 230,299,000 212,375,000 209,900,000  171,438,000 144,522,000 147,292,000 382,096,000 118,094,000 113,346,000 109,818,000         
      total revenue
    		               248,358,000 222,471,000 222,057,000 215,071,000 271,923,000 264,593,000 238,632,000 247,285,000  220,143,000 191,959,000 197,756,000 477,116,000 149,947,000 144,298,000 139,714,000 327,038,000 107,912,000 107,071,000 106,238,000 193,978,000 60,210,000 56,518,000  
      loss on extinguishment of debt
    		                   -9,578,000 4,789,000                   
      goodwill impairment
    		                     215,100,000                  
      change in fair value of contingent consideration and indemnification asset
    		               14,100,000 -225,000  -594,000 4,352,000 2,570,000 756,000 -3,818,000  -500,000 100,000  -4,204,000 100,000 -1,604,000          
      impairment of equity method investments
    		                      -47,133,000                 
      benefit for income taxes
    		               -453,000 234,000 91,000  -422,000 503,000 -3,904,000 270,000  -849,000 1,398,000 -496,000 -95,000 135,000 -109,000 3,000 -4,923,000 -1,714,000 -700,000 405,000 -10,499,000 -256,000 -371,000  
      net income attributable to non-controlling interests
    		                   -205,500 -822,000    -217,000 -285,000 -1,910,000 -1,407,000 -126,000 -115,000 -439,000 -8,561,000 -541,000 -2,793,000 -5,137,000 -62,469,000 -4,567,000 -3,612,000  
      total comprehensive loss
    		               -5,646 -13,036 -9,165 -9,838 -13,761,000 -38,099,000 -203,525,000 -78,905,000                 
      total comprehensive loss attributable to non-controlling interests
    		                   -205,500 -822,000                   
      gain from discontinued operations, net of tax
    		                  1,383,000                     
      premiums
    		                   30,241,000 29,487,000 25,502,000 32,147,000  43,521,000 45,493,000 47,111,000 71,334,000 22,623,000 22,737,000 23,391,000         
      claims expenses
    		                   24,815,000 21,325,000 18,144,000 23,667,000  34,802,000 36,085,000 37,757,000 53,897,000 16,992,000 18,428,000 16,749,000         
      (gain) loss on disposal of assets
    		                   1,611,750      -9,600,000              
      income before income taxes and non-controlling interests
    		                   -14,225,000 -37,667,000 -207,425,000 -78,482,000  -26,587,000 -30,502,000 -49,145,000 -41,731,000 -12,420,000 -10,140,000 -14,062,000 -61,561,000 -14,843,000 -20,398,000 -22,744,000 -221,502,000 -16,031,000 -12,370,000  
      income from equity method investees
    		                      -412,000  -3,859,000 -1,904,000 -424,000 -3,355,000 -1,381,000           
      cost of revenue (exclusive of depreciation and amortization
    		                                       
      expenses presented separately below)
    		                        131,763,000 108,383,000 117,441,000 253,858,000 73,967,000 69,003,000 71,975,000 201,071,000 68,281,000 67,994,000 67,528,000 121,272,000 33,905,000 32,779,000  
      net income attributable to evolent health, inc.
    		                        -25,521,000 -31,615,000 -46,739,000 -40,229,000 -12,429,000 -9,916,000 -13,626,000 -48,077,000 -12,588,000 -16,905,000 -18,012,000 -148,534,000 -11,208,000 -8,387,000  
      earnings available for common shareholders
    		                                       
      basic and diluted
    		                        -25,521,000 -31,615,000 -46,739,000             
      earnings per common share
    		                                       
      basic and diluted
    		                        -300 -380 -590             
      total comprehensive income
    		                        -25,806,000 -31,889,000 -48,625,000 -41,702,000 -12,671,000 -10,179,000 -14,065,000         
      total comprehensive income attributable to non-controlling interests
    		                        -217,000 -285,000 -1,910,000 -1,407,000 -126,000 -115,000 -439,000         
      total comprehensive income attributable to evolent health, inc.
    		                        -25,589,000 -31,604,000 -46,715,000 -40,295,000 -12,545,000 -10,064,000 -13,626,000         
      earnings available for common shareholders
    		                                       
      basic
    		                           -3,107,250 -12,429,000 -9,916,000 -13,626,000 -48,077,000 -12,588,000 -16,905,000 -18,012,000 -148,534,000 -11,208,000 -8,387,000  
      diluted
    		                           -3,107,250 -12,429,000 -9,916,000 -13,626,000 -48,077,000 -12,588,000 -16,905,000 -18,012,000 -148,534,000 -11,208,000 -8,387,000  
      earnings per common share
    		                                       
      basic
    		                           -40 -160 -130 -180 -760 -180 -280 -340 -3,290 -260 -200  
      diluted
    		                           -40 -160 -130 -180 -760 -180 -280 -340 -3,290 -260 -200  
      income from equity affiliates
    		                             -1,275,000          
      loss on change in fair value of contingent consideration
    		                              100,000 25,000 100,000 200,000      
      income from affiliates
    		                              -131,000 -92,250 -369,000 -555,000 -522,000 -393,000 -448,000 -14,000  
      transformation
    		                               21,262,000 8,204,000 5,361,000 10,235,000 30,563,000 7,757,000 10,388,000  
      platform and operations
    		                               305,776,000 99,708,000 101,710,000 96,003,000 163,415,000 52,453,000 46,130,000  
      gain on consolidation
    		                                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.